Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Sanofi-Aventis S.A. ADR (SNY)
Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 117,170,240
  • Shares Outstanding, K 2,529,582
  • Annual Sales, $ 47,822 M
  • Annual Income, $ 8,820 M
  • 60-Month Beta 0.59
  • Price/Sales 2.57
  • Price/Cash Flow 8.00
  • Price/Book 1.46
Trade SNY with:

Options Overview Details

View History
  • Implied Volatility 20.11% ( -2.12%)
  • Historical Volatility 64.20%
  • IV Percentile 14%
  • IV Rank 17.99%
  • IV High 37.86% on 01/20/23
  • IV Low 16.21% on 08/23/23
  • Put/Call Vol Ratio 0.27
  • Today's Volume 678
  • Volume Avg (30-Day) 1,637
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 50,868
  • Open Int (30-Day) 44,154

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.94
  • Number of Estimates 4
  • High Estimate 1.04
  • Low Estimate 0.89
  • Prior Year 0.87
  • Growth Rate Est. (year over year) +8.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.13 +2.64%
on 11/15/23
47.68 -2.85%
on 11/27/23
+0.54 (+1.18%)
since 11/08/23
3-Month
42.63 +8.66%
on 10/27/23
55.72 -16.87%
on 09/20/23
-7.27 (-13.57%)
since 09/08/23
52-Week
42.63 +8.66%
on 10/27/23
57.82 -19.89%
on 04/26/23
-0.60 (-1.28%)
since 12/08/22

Most Recent Stories

More News
2 Biotech Stocks You Can Buy and Hold for the Next Decade

These stocks aren't popular on the market right now, but investors shouldn't let that scare them off.

SNY : 46.32 (+0.56%)
GILD : 79.02 (+1.24%)
Informatica soars on its AI-powered data management cloud growth

Enterprise cloud data management software provider Informatica Co. (NASDAQ: INFA) saw its shares surge 23% on its impressive Q3 2023 earnings report. The compa

F : 11.01 (+1.76%)
PG : 145.15 (-0.92%)
INFA : 27.33 (+0.89%)
AMZN : 147.42 (+0.37%)
INTC : 42.70 (+1.30%)
SNYNF : 93.2000 (+2.89%)
SNY : 46.32 (+0.56%)
SAN : 4.20 (+1.20%)
SHEL : 64.14 (+1.38%)
SHEL.LN : 2,520.500 (+1.59%)
RTX : 81.32 (-0.22%)
MarketBeat Week in Review – 11/6 - 11/10

Stocks closed the week with a strong rally, but the rally may reverse when investors get the latest information about inflation and retail stocks next week

FSLY : 17.27 (+2.55%)
PFE : 28.78 (+0.52%)
SNY : 46.32 (+0.56%)
RIVN : 19.04 (-0.78%)
NVDA : 475.06 (+1.95%)
QCOM : 132.97 (+0.02%)
BIRK : 47.91 (+1.08%)
VRTX : 350.15 (-1.07%)
ABNB : 140.68 (+0.60%)
INTC : 42.70 (+1.30%)
LYV : 85.19 (+1.08%)
PLTR : 17.77 (+3.19%)
Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time

There are very good reasons that stocks generally gain in value after a company receives %OrphanDrug designation (ODD). A study published in Orphanet Journal of Rare Diseases showed that the average stock...

SNY : 46.32 (+0.56%)
TAK : 14.06 (-0.14%)
NRX.VN : 0.310 (-1.59%)
BMY : 50.31 (+0.30%)
NRX : 0.14 (+7.69%)
Pfizer and Sanofi shares fall, which one to scoop up?

Pharmaceutical stocks aren't having a banner year; notably, two large pharmaceutical companies recently plunged to 52-week lows

PFE : 28.78 (+0.52%)
SNY : 46.32 (+0.56%)
SNYNF : 93.2000 (+2.89%)
SAN : 4.20 (+1.20%)
MDCO : 84.90 (-0.07%)
This Stock Just Dropped By 15%: Is It a Buy?

Now could be a great opportunity to buy low.

SNY : 46.32 (+0.56%)
Get Ready for Next Generation of Diabetes, Weight-Management Drugs

NetworkNewsWire Editorial Coverage : GLP-1 agonists have become incredibly popular obesity drugs, reshaping the standard of care as people increasingly turn to the new class of drugs in lieu of conventional...

LEXX : 1.3500 (-6.25%)
JNJ : 154.42 (-0.63%)
SNY : 46.32 (+0.56%)
AMGN : 269.12 (-0.81%)
NVS : 96.30 (+0.39%)
Get Ready for Next Generation of Diabetes, Weight-Management Drugs

EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END

LEXX : 1.3500 (-6.25%)
JNJ : 154.42 (-0.63%)
SNY : 46.32 (+0.56%)
AMGN : 269.12 (-0.81%)
NVS : 96.30 (+0.39%)
Investor patience tested as pharmaceutical stocks take a tumble

The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector

SPY : 460.20 (+0.43%)
ABBV : 149.28 (+0.89%)
AMGN : 269.12 (-0.81%)
LLY : 598.05 (+1.66%)
XLV : 132.07 (+0.17%)
JNJ : 154.42 (-0.63%)
MRK : 103.75 (-0.13%)
NVO : 96.64 (-0.18%)
PFE : 28.78 (+0.52%)
SNY : 46.32 (+0.56%)
XLU : 63.41 (-0.19%)
BMY : 50.31 (+0.30%)
This High-Yielding ETF Gives Investors Great Exposure to European Stocks

If you’re looking for a top exchange-traded fund (ETF) to hold in your portfolio and which can ...

ZWP.TO : 17.41 (+0.29%)
UL : 47.45 (-1.02%)
SNY : 46.32 (+0.56%)
NVO : 96.64 (-0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sanofi-Aventis manufactures & markets prescription drugs across countries. It focuses on major therapeutic areas such as multiple sclerosis, cardiovascular, immunology, neurology, oncology, rare blood disorders & diabetes, etc. By taking Genzyme Corporation as a subsidiary, it added products like Cerezyme,...

See More

Key Turning Points

3rd Resistance Point 46.85
2nd Resistance Point 46.67
1st Resistance Point 46.49
Last Price 46.32
1st Support Level 46.13
2nd Support Level 45.95
3rd Support Level 45.77

See More

52-Week High 57.82
Fibonacci 61.8% 52.02
Fibonacci 50% 50.22
Fibonacci 38.2% 48.43
Last Price 46.32
52-Week Low 42.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar